Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11
November 7, 2024 4:38 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11). Revenue for the quarter came in at $9.09 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More